Radiculopathy associated with disc herniation

Annals of the Rheumatic Diseases

Volumn 65, Issue 2, 2006, Pages 141-143

  Goupille, P ^a,b   Mulleman, D ^a,b   Valat, J P ^a,b  

^a UNIVERSITÉ DE TOURS   (France)

^b SERVICE DE DERMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; DOXYCYCLINE; ETANERCEPT; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ALLODYNIA; CLINICAL TRIAL; DISEASE ASSOCIATION; EDITORIAL; HUMAN; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; INTERVERTEBRAL DISK HERNIA; ISCHIALGIA; MECHANICAL STRESS; NEUROTOXICITY; NONHUMAN; NUCLEUS PULPOSUS; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADICULOPATHY; SIDE EFFECT;

ANIMALS; ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOGLOBULIN G; INTERVERTEBRAL DISK; INTERVERTEBRAL DISK DISPLACEMENT; MODELS, ANIMAL; RADICULOPATHY; RANDOMIZED CONTROLLED TRIALS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 31144458617     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.039669     Document Type: Editorial

References (30)

1. Cooper RG, Freemont AJ. TNF-alpha blockade for herniated intervertebral disc-induced sciatica: way forward at last? Rheumatology (Oxford) 2004;43:119-21.
2. Mulleman D, Mammou S, Griffoul I, Watier H, Goupille P. Pathophysiology of disk-related sciatica. I.-Evidence supporting a chemical component. Joint Bone Spine 18 Jul 2005 [Epub ahead of print].
3. Mulleman D, Mammou S, Griffoul I, Watier H, Goupille P. Pathophysiology of disk-related low back pain and sciatica. II.-Evidence supporting treatment with TNF-alpha antagonists. Joint Bone Spine 18 Jul 2005 [Epub ahead of print].
4. Mixter WJ, Barr JS. Rupture of the intervertebral disc with involvement or the spinal canal. N Engl J Med 1934;211:210-15.
5. Yorimitsu E, Chiba K, Toyama Y, Hirabayashi K. Long-term outcomes of standard discectomy for lumbar disc herniation. Spine 2001;26:652-7.
6. o Malter AD, McNeney B, Loeser JD, Deyo RA. Five-year reoperation rates after different types of lumbar spine surgery. Spine 1998;23:814-20.
7. Boden SD, Davis DO, Dina TS, Patronas NJ, Wiesel SE. Abnormal magnetic resonance scans of the lumbar spine in asymptomatic subjects: a prospective investigation. J Bone Joint Surg Am 1990;72:403-8.
8. Boos N, Rider R, Schade V, Spratt KF, Semmer N, Aebi M. Volvo Award in clinical sciences. The diagnostic accuracy of magnetic resonance imaging, work perception, and psychosocial factors in identifying symptomatic disc herniations. Spine 1995;15:2613-25.
9. Valls I, Saraux A, Goupille P, Khoreichi A, Baron D, Le Goff P. Factors predicting radical treatment after in-hospital conservative management of disk-related sciatica. Joint Bone Spine 2001;68:50-8.
10. Atlas SJ, Keller RB, Chang Y, Deyo RA, Singer DE. Surgical and non surgical management of sciatica secondary to a lumbar disc herniation. Five-year outcomes from the Maine lumbar spine study. Spine 2001;26:1179-87.
11. Weber H. Lumbar disc herniation: a controlled, prospective study with ten years of observation. Spine 1983;8:131-40.
12. Haro H, Kato T, Komori H, Shinomiya K. Sequential dynamics of inflammatory cytokines, angiogenesis inducing factor and matrix degrading enzymes during spontaneous resorption of the herniated disc. J Orthop Res 2004;22:895-900.
13. Saal JA, Saal JS, Herzog RJ. The natural history of lumbar intervertebral disc extrusions treated nonoperatively. Spine 1990;15:683-6.
14. Olmarker K, Blomquist J, Strömberg J, Nannmark U, Thomsen P, Rydevik B. Inflammatogenic properties of nucleus pulposus. Spine 1995;20:665-9.
15. Goupille P, Jayson MI, Valat JP, Freemont AJ. The role of inflammation in disk herniation-associated radiculopathy. Semin Arthritis Rheum 1998;28:60-71.
16. Goupille P, Jayson MI, Valat JP, Freemont AJ. Matrix metalloproteinases: the clue to intervertebral disc degeneration? Spine 1998;23:1612-26.
17. Cavanaugh JM. Neural mechanisms of lumbar pain. Spine 1995;16:1804-9.
18. Kulisch SD, Ulstrom CL, Michael CJ. The tissue origin of low-back pain and sciatica: a report of pain response to tissue stimulation during operations on the lumbar spine using local anesthesia. Ortnop Clin North Am 1991;22:181-7.
19. Olmarker K, Rydevik B, Nordborg C. Autologous nucleus pulposus induces neurophysiologic and histologic changes in porcine cauda equina nerve roots. Spine 1993;18:1425-32.
20. Olmarker K, Byrod G, Cornefjord M, Nordborg C, Rydevik B. Effects of methylprednisolone on nucleus pulposus-induced nerve root injury. Spine 1994;19:1803-8.
21. Byrod G, Otani K, Brisby H, Rydevik B, Olmarker K. Methylprednisolone reduces the early vascular permability increase in spinal nerve roots induced by epidural nucleus pulposus application. J Orthop Res 2000;18:983-7.
22. Olmarker K, Brisby H, Yabuki S, Nordborg C, Rydevik B. The effects of normal, frozen, and hyaluronidase-digested nucleus pulposus on nerve root structure and function. Spine 1997;22:471-5.
23. Myers RR. The pathogenesis of neuropathic pain. Reg Anaesth 1995;20:173-84.
24. Olmarker K, Larsson K. Tumor necrosis factor alpha and nucleus-pulposus-induced nerve root injury. Spine 1998;23:2538-44.
25. Igarashi T, Kikuchi S, Shubayev V, Myers RR. Volvo Award winner in basic science studies. Exogenous tumor necrosis factor-alpha mimics nucleus pulposus-induced neuropathology. Molecular, histologic, and behavioral comparisons in rats. Spine 2000;25:2975-80.
26. Wagner R, Myers RR. Endoneurial injection of TNF-alpha produces neuropathic pain behaviors. Neuroreport 1996;7:2897-901.
27. Aoki Y, Rydevik B, Kikuchi S, Olmarker K. Local application of disc-related cytokines on spinal nerve roots. Spine 2002;27:1614-17.
28. Karppinen J, Korhonen T, Malmivaara A, Paimela L, Kyllonen E, Lindgren KA, et al. Tumor necrosis factor-alpha monoclonal antibody, infliximab, used to manage severe sciatica. Spine 2003;28:750-3.
29. Genevay S, Stingelin S, Gabay C. Efficacy of etanercept in the treatment of acute, severe sciatica: a pilot study. Ann Rheum Dis 2004;63:1120-3.
30. Korhonen T, Karppinen J, Paimela L, Malmivaara A, Lindgren KA, Järvinen S, et al. The efficacy of infliximab for disc herniation-induced sciatica. A three-month follow-up of First II, a randomised controlled trial. Annual meeting of the International Society for the Study of the Lumbar Spine, Spine Week, Porto, May, 2004.